🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Millennium Development Goal of reducing the maternal mortality ratio by...
Status
Completed
Location
Aswan University
Start Date
2018-12-01
Trial ID
NCT03710317
Treatments Being Tested
Carbetocin is an oxytocin receptor agonist that selectively binds to recept...
Status
Completed
Location
Ferring Investigational Site
Start Date
2023-05-25
Trial ID
NCT05924321
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of in...
Status
Completed
Location
Florida University
Start Date
2014-01-20
Trial ID
NCT01968187
Purpose to evaluates the effects of oxytocin infusion with or without intra...
Status
Unknown
Location
Aswan University
Start Date
2019-01-01
Trial ID
NCT03777878
Treatments Being Tested
Background: Carbetocin is an established single-dose uterotonic agent for p...
Status
Not Yet Recruiting
Location
Qassim University Medical City
Start Date
2026-08
Trial ID
NCT07636421
Treatments Being Tested
Postpartum hemorrhage is an important cause of maternal morbidity and morta...
Status
Unknown
Location
Saint Thomas H
Start Date
2012-01
Trial ID
NCT01382732
Treatments Being Tested
12-week, randomized, double-blind, placebo-controlled, parallel-group study...
Status
Active Not Recruiting
Location
Children's of Alabama
Start Date
2023-11-27
Trial ID
NCT06173531
Treatments Being Tested
Submucous myomas represent one of the main indications of operative hystero...
Status
Completed
Location
Faculty of Medicine
Start Date
2020-07-15
Trial ID
NCT04482959
Treatments Being Tested
This Phase 3 study is designed to test the effectiveness of intranasal carb...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-11-20
Trial ID
NCT03649477
Treatments Being Tested
Several randomized, controlled trials, mostly involving women undergoing ce...
Status
Recruiting
Location
CHU Bordeaux
Start Date
2020-08-07
Trial ID
NCT04304625
Treatments Being Tested